Collectively, IGF2BP1 could promote epithelial–mesenchymal transition as well as migration and invasion potentials of tumor cells by mediating m6A methylation; hence, the m6A/IGF2BP1 axis is beneficial for triggering tumor metastasis. The gene discussed is IGF2BP1; the disease is neoplasm.